Overall, we demonstrated that WTAP affected m6A methylation of NOA1, induced mitochondrial damage, activated the GPX4 expression, reduced the Fe2+ levels and improved GSH/GSSH levels to inhibit lipid oxidation, which may regulate the occurrence and development of HCC. The gene discussed is NOA1; the disease is hepatocellular carcinoma.